Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involvin...
Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome
About this item
Full title
Author / Creator
Ma, Zejun , Zhu, Lili , Wang, Shangshang , Guo, Xin , Sun, Bei , Wang, Qilong and Chen, Liming
Publisher
England: Taylor & Francis
Journal title
Language
English
Formats
Publication information
Publisher
England: Taylor & Francis
Subjects
More information
Scope and Contents
Contents
Accumulating evidence has implicated that berberine (BBR) has a beneficial effect on diabetic kidney disease (DKD), but its mechanism is not clear. The aim of this study was to assess whether berberine could alleviate tubulointerstitial fibrosis and attenuate epithelial-to-mesenchymal transition (EMT) and its possible molecular mechanism. High-fat...
Alternative Titles
Full title
Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2671265219
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2671265219
Other Identifiers
ISSN
0886-022X
E-ISSN
1525-6049
DOI
10.1080/0886022X.2022.2079525
